GlassScriptPhysician profile
Beth A Hite
NPI 1073040200
$8,687.79
in general payments reported to CMS, 2019-2025
33 companies · $2,237 in 2025
The $2,237 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,780 · 2022: $1,553 · 2023: $1,524 · 2024: $1,593 · 2025: $2,237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,331 · Education: $24.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,330.63 |
| Education | $24.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,612.61 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $1,307.77 | 2021-2025 | Dexcom G6 Transmitter, Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Lilly USA, LLC | $744.95 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Amgen INC. | $661.05 | 2022-2025 | Evenity, Prolia, Repatha |
| Medtronic, INC. | $568.07 | 2021-2023 | Minimed 780g |
| Abbott Laboratories | $558.42 | 2021-2025 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $419.41 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $402.75 | 2021-2025 | Omnipod |
| Inspire Medical Systems, INC. | $342.19 | 2024-2025 | Inspire |
| Mannkind Corporation | $264.90 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $256.81 | 2021-2022 | |
| Beta Bionics, INC. | $181.91 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.11 | 2021-2025 | Jardiance, Ofev |
| Xeris Pharmaceuticals, INC. | $155.31 | 2022-2024 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $131.66 | 2021-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $129.04 | 2021-2025 | |
| Boston Scientific Corporation | $122.75 | 2025 | Lux-Dx Insertable Cardiac Monitor |
| Astellas Pharma US INC | $117.09 | 2023-2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $98.58 | 2022-2024 | |
| Recordati_rare_diseases_inc. | $69.72 | 2023-2025 | Isturisa, Signifor Lar |
| Amarin Pharma, INC. | $68.47 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $46.25 | 2024 | Acthar |
| Horizon Therapeutics Plc | $41.39 | 2021-2023 | Tepezza |
| Ibsa Pharma INC. | $37.66 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $37.23 | 2021-2024 | Unithroid |
| Merck Sharp & Dohme LLC | $27.56 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $24.04 | 2025 | |
| Halozyme INC | $20.33 | 2023 | |
| Antares Pharma, INC. | $18.07 | 2022 | |
| Corcept Therapeutics | $17.73 | 2021 | |
| Zealand Pharma US, INC. | $16.53 | 2022 | |
| Amphastar Pharmaceuticals, INC. | $14.08 | 2024 | Baqsimi |
| Otsuka America Pharmaceutical, INC. | $13.35 | 2023 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Hite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.